| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| ELITE PHARMACEUTICALS INC /NV/ | CEO, President, Director, 10%+ Owner | Common Stock | 216,649,250 | $14,948,798 | $0.0690 | 29 Mar 2024 | Direct |
| ELITE PHARMACEUTICALS INC /NV/ | CEO, President, Director, 10%+ Owner | Common Stock | 2,700,000 | $186,300 | $0.0690 | 29 Mar 2024 | by IRA |
| ELITE PHARMACEUTICALS INC /NV/ | CEO, President, Director, 10%+ Owner | Common Stock | 2,223,147 | $153,397 | $0.0690 | 29 Mar 2024 | by Kristine Hakim |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| ELTP | ELITE PHARMACEUTICALS INC /NV/ | 29 Mar 2024 | 1 | $0 | 4 | CEO, President, Director, 10%+ Owner | 02 Apr 2024, 16:58 |
| ELTP | ELITE PHARMACEUTICALS INC /NV/ | 29 Dec 2023 | 0 | $0 | 4/A | CEO & President, Director, 10%+ Owner | 02 Apr 2024, 16:56 |
| ELTP | ELITE PHARMACEUTICALS INC /NV/ | 29 Dec 2023 | 1 | +$153,397 | 4 | CEO, President, Director, 10%+ Owner | 29 Dec 2023, 14:21 |